RESULTS OF FRACTIONATED RADIOIODINE THERAPY IN 696 THYROTOXICOSIS PATIENTS AND IN 690 PERSONS WITH SIMPLE GOITER

被引：0
|
作者：
KLEIN, B [1 ]
KLEIN, E [1 ]
HORSTER, FA [1 ]
机构：
[1] UNIV DUSSELDORF,MED KLIN C & POLIKLIN,D-4000 DUSSELDORF 1,FED REP GER
来源：
NUKLEARMEDIZIN | 1989年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：129 / 136
页数：8
相关论文
共 50 条
  • [21] Radioiodine therapy in patients with Graves' disease and toxic multinodular goiter in a Scottish population - Comparision of efficacy of two different doses
    Ghosh, S.
    Roychoudhury, A.
    Collier, A.
    Malik, I.
    Sarkar, S.
    Pal, J.
    HORMONE RESEARCH, 2007, 68 : 81 - 81
  • [22] Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter
    Nieuwlaat, WA
    Huysmans, DA
    van den Bosch, HC
    Sweep, CG
    Ross, HA
    Corstens, FH
    Hermus, AR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07): : 3121 - 3129
  • [23] Effects of 0.1 mg recombinant-Human-Thyrotropin stimulated radioiodine therapy in patients with recurrent multinodular goiter.
    Iakovou, I.
    Angelopoulos, N.
    Doumas, A.
    Badiavas, K.
    Balaris, V.
    Nikos, V.
    Christiforidis, T.
    Georga, S.
    Lo Presti, D.
    Magouretsios, G.
    Gartsioni, S.
    Karatzas, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S339 - S339
  • [24] Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter
    Bonnema, SJ
    Nielsen, VE
    Hegedüs, L
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12): : 6113 - 6114
  • [25] Short course of oral lithium therapy as an adjunct in patients with thyrotoxicosis who failed initial radioiodine therapy: should this be worthwhile to consider in the absence of contraindications?
    Basu, Sandip
    Abhyankar, Amit
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (08) : 726 - 727
  • [26] Radioiodine therapy in elderly patients with subclinical hyperthyroidism due to non-voluminous nodular goiter and its effect on bone metabolism
    Rosario, Pedro Weslley
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2013, 57 (02) : 144 - 147
  • [27] PATIENTS REFERENCE PERSONS - INVESTIGATION RESULTS OF AN AMBULATORY GROUP-THERAPY
    FRITZSCHE, M
    GOLLNER, R
    GRUPPENPSYCHOTHERAPIE UND GRUPPENDYNAMIK, 1976, 11 (01) : 47 - 59
  • [28] Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy
    Kaniuka-Jakubowska, Sonia
    Lewczuk, Anna
    Majkowicz, Mikolaj
    Piskunowicz, Maciej
    Mizan-Gross, Krystyna
    Zapasnik, Adam
    Kaszubowski, Mariusz
    Lass, Piotr
    Sworczak, Krzysztof
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [29] The predictive role of 24h RAIU with respect to the outcome of low fixed dose radioiodine therapy in patients with diffuse toxic goiter
    Damle, Nishikant
    Bal, Chandrasekhar
    Kumar, Praveen
    Reddy, Ramamohan
    Virkar, Deepali
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 11 (04): : 451 - 457
  • [30] Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone
    Nieuwlaat, WA
    Hermus, AR
    Ross, HA
    Buijs, WC
    Edelbroek, MA
    Bus, JW
    Corstens, FH
    Huysmans, DA
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (04) : 626 - 633
12345